A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor ...

Information on How Functional Medicine Testing Chicago Helps Identify Root Causes of Chronic Health Issues ...

AMDS™ Hybrid Prothesis is the first device designed specifically to address the unique challenges of acute DeBakey Type I aortic dissections complicated by malperfusion. It’s unique stent-supported ...

Chronic symptoms are genuinely hard to explain in a single appointment. Fatigue, digestive trouble, hormonal shifts, and persistent inflammation can each look normal on a standard panel. Conventional ...

The program introduces two of the world’s most advanced PFA technologies-Medtronic PulseSelect™ at Alwarpet and Biosense Webster Varipulse™ at Vadapalani, the latter integrated with an advanced 3D ...

The X1 is an outstanding RF system offering a cost-effective balance of functionality to support a wide range of general RF applications, such as chest, abdomen, or extremities along with Upper GI's, ...

Conan Cavanagh has over 25 years of experience in the development of medical devices, biomaterials, and product commercialization Bioretec Ltd, a pioneer in absorbable orthopedic implants, has ...

New generation catheters integrating SlipStream™ technology and patented insertion system now available to healthcare professionals in Canada, reinforcing Vygon’s extensive range in vascular access ...

New research presented at the 2026 SOSORT International Congress in Italy demonstrates the power of custom 3D bracing and consistent patient care As National Scoliosis Awareness Month continues this ...

Aiying Sun, EVP, Quality, Regulatory and Clinical Affairs at AMDI. "Pursuing the FDA's dual 510(k) clearance and CLIA waiver pathway was a deliberate strategy to bring this innovation to market with ...

"This is an important proposal that will hopefully spark crucial conversations across the clinical laboratory community," said Jonathan Genzen, MD, PhD, MBA, chief medical officer and senior director ...

CellLife notes the licensing agreement builds on their existing proprietary dendritic cell platform, which has demonstrated long-term durability in preventing relapse in pediatric patients with ...